Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system
Shuofeng Yuan, Jasper Fuk‐Woo Chan, Kenn Ka-Hang Chik, Chris Chun-Yiu Chan, Jessica Oi‐Ling Tsang, Ronghui Liang, Jianli Cao, Kaiming Tang, Lin‐Lei Chen, Kun Wen, Jian‐Piao Cai, Zi‐Wei Ye, Gang Lu, Hin Chu, Dong‐Yan Jin, Kwok‐Yung Yuen
Topics & Concepts
Coronavirus disease 2019 (COVID-19)BexaroteneAbirateroneMedicinePharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrug approvalDrugVirologyChemistryInternal medicineProstate cancerCancerBiochemistryTranscription factorDiseaseInfectious disease (medical specialty)Nuclear receptorGeneOutbreakAndrogen receptorVitamin C and Antioxidants ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research